Literature DB >> 15039094

Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.

Tania Carmenate1, Leonardo Canaán, Anabel Alvarez, Maité Delgado, Sonia González, Tamara Menéndez, Lorenzo Rodés, Gerardo Guillén.   

Abstract

Neisseria meningitidis serogroup C polysaccharide (CCPS) was conjugated to the carrier protein P64k using two different conjugation procedures, condensation mediated by carbodiimide with adipic acid dihydrazide as spacer and the reductive amination method. BALB/c mice were immunized with the resultant polysaccharide-protein conjugates and the immune response was evaluated. All conjugates assayed generated at least 10-fold higher antibody titers than the free polysaccharide. The reductive amination method rendered the best conjugate (CCPS-P64kR) that was able to elicit antibody titers statistically higher than the titer elicited by the plain CCPS (P<0.001). The sera of the group immunized with CCPS-P64kR showed a three-fold higher bactericidal response than the sera of the group immunized with the plain CCPS and they were able to protect against challenge with meningococci in the infant rat protection model. In addition, three different conjugates were obtained from polysaccharides with molecular relative sizes of 2000-4000 Da, 4000-10,000 Da or 10,000-50,000 Da, but no differences were detected in the immune response obtained against the three conjugates. Our experiments demonstrate that it is possible to generate a protective, T-cell-dependent response against CCPS using the P64k protein as carrier.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039094     DOI: 10.1016/S0928-8244(03)00346-8

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  8 in total

1.  Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.

Authors:  Tamara Menéndez; Tania Carmenate; Yoelys Cruz-Leal; Edelgis Coizeau; Evelyn Caballero; Daniel Bello; María Guirola; Anabel Alvarez; Gerardo Guillén
Journal:  Curr Microbiol       Date:  2009-09-23       Impact factor: 2.188

2.  Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Authors:  Francesca Micoli; Maria Rosaria Romano; Marta Tontini; Emilia Cappelletti; Massimiliano Gavini; Daniela Proietti; Simona Rondini; Erwin Swennen; Laura Santini; Sara Filippini; Cristiana Balocchi; Roberto Adamo; Gerd Pluschke; Gunnstein Norheim; Andrew Pollard; Allan Saul; Rino Rappuoli; Calman A MacLennan; Francesco Berti; Paolo Costantino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

3.  Site-specific scFv labelling with invertase via Sortase A mechanism as a platform for antibody-antigen detection using the personal glucose meter.

Authors:  Nur Faezee Ismail; Theam Soon Lim
Journal:  Sci Rep       Date:  2016-01-19       Impact factor: 4.379

4.  Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses.

Authors:  Mostafa A Elbahnasawy; Luke R Donius; Ellis L Reinherz; Mikyung Kim
Journal:  Vaccine       Date:  2018-09-07       Impact factor: 3.641

Review 5.  Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.

Authors:  Chakkumkal Anish; Michel Beurret; Jan Poolman
Journal:  NPJ Vaccines       Date:  2021-12-10       Impact factor: 7.344

Review 6.  Impact and Control of Sugar Size in Glycoconjugate Vaccines.

Authors:  Giuseppe Stefanetti; Calman Alexander MacLennan; Francesca Micoli
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

7.  Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus.

Authors:  Roberta Di Benedetto; Francesca Mancini; Martina Carducci; Gianmarco Gasperini; Danilo Gomes Moriel; Allan Saul; Francesca Necchi; Rino Rappuoli; Francesca Micoli
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

8.  Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K carrier protein from Neisseria meningitidis.

Authors:  Luis Javier González; Pedro E Encinosa Guzmán; Wendy Machado; Satomy Pousa; Alejandro Leyva; Ana Laura Cano Arguelles; Gleysin Cabrera; Luis Ariel Espinosa; Rubén Parra; Rachel Hernández; Yamil Bello Soto; Frank L Ledesma; Marisdania Joglar; Osmany Guirola; Louise Ulrich Kurt; Paulo C Carvalho; Ania Cabrales; Hilda Garay; Vladimir Besada; Rosario Durán; Toshifumi Takao; Mario Pablo Estrada; Alina Rodríguez-Mallon
Journal:  Anal Bioanal Chem       Date:  2021-08-03       Impact factor: 4.478

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.